Sertraline Tablets

Sol #SPE2D2-26-D-0012Award Notice$22,510,721

General

Organization:
DLA TROOP SUPPORT
Department:
TROOP SUPPORT MEDICAL
Next Response Deadline:
N/A
Posted:
Apr 21, 2026
Modified:
Apr 21, 2026
Archive:
N/A

Award Details

General

Awardee:EXELAN PHARMACEUTICALS INC
Awarded:Apr 21, 2026
Amount:$22,510,721

Details

Award Number:SPE2D2-26-D-0012
Entity ID:FYZXNHSQTMG8
Cage Code:6GFC4
Business Location:Boca Raton Florida, UNITED STATES - 33432

Classification

NAICS:
Pharmaceutical Preparation Manufacturing (325412)
Product Service Code (PSC):
DRUGS AND BIOLOGICALS(6505)
Set-Aside:
N/A

Place of Performance

Hauppauge New York, UNITED STATES - 11788

Point of Contact

Christopher Newman(primary)
christopher.newman@dla.mil
4457377371
Jason Wray(secondary)
jason.wray@dla.mil
4457376304

Description

SPE2D2-26-D-0012 Sertraline Tablets Follow-On Award

AI Analysis

Scope

pharmaceuticalsmedicationtabletshealthcaresertraline
Ceiling Value: N/A
Pricing Model: unknown

Risk Factors

  • regulatory compliance
  • supply chain disruptions
  • quality control issues
  • market competition

Attachments

loading files....

Files

  • SPE2D2-26-D-0012 Award Signed.pdf

Links

No external links have been added to this opportunity
View on SAM.gov